Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Pediatric Nephrology (Berlin, Germany)
|
April 27, 2021
Associations among erythropoietic, iron-related, and FGF23 parameters in pediatric kidney transplant recipients
Blair Limm-Chan, Katherine Wesseling-Perry, Meghan H Pearl, et al.
Pediatric Nephrology (Berlin, Germany)
|
September 26, 2023
Associations between anemia and FGF23 in the CKiD study
Elizabeth Thomas, Alexandra M Klomhaus, Marciana L Laster, et al.
American Journal of Physiology. Renal Physiology
|
October 14, 2016
Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice
Mark R Hanudel, Kristine Chua, Maxime Rappaport, et al.
The Analyst
|
January 22, 2020
Measurement of serum phosphate levels using a mobile sensor
Aniruddha Ray, Sarah Esparza, Dimei Wu, et al.
JCI Insight
|
August 7, 2025
Transgenic augmentation of erythroferrone in mice ameliorates anemia in adenine-induced chronic kidney disease
Brian Czaya, Joseph D Olivera, Moya Zhang, et al.
JBMR Plus
|
April 18, 2022
Effects of Primary Kidney Disease Etiology on Renal Osteodystrophy in Pediatric Dialysis Patients
Ornatcha Sirimongkolchaiyakul, Katherine Wesseling-Perry, Barbara Gales, et al.
Plos One
|
September 6, 2019
Plasma total fibroblast growth factor 23 levels are associated with acute kidney injury and mortality in children with acute respiratory distress syndrome
Mark R Hanudel, Matthew S Zinter, Lucia Chen, et al.
Blood. Red Cells & Iron
|
February 2, 2026
Disease-modifying effects of iron deficiency in mouse models of chronic renal failure
Moya Zhang, Amber Lundin, Grace Jung, et al.
Kidney International
|
November 28, 2021
Enteral ferric citrate absorption is dependent on the iron transport protein ferroportin
Mark R Hanudel, Brian Czaya, Shirley Wong, et al.
Cancer Research Communications
|
September 13, 2024
Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis
Jack Pengfei Tang, Penelope Lafeuille, Alexandru Socolov, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Pediatric Nephrology (Berlin, Germany)
|
April 27, 2021
Associations among erythropoietic, iron-related, and FGF23 parameters in pediatric kidney transplant recipients
Blair Limm-Chan, Katherine Wesseling-Perry, Meghan H Pearl, et al.
Pediatric Nephrology (Berlin, Germany)
|
September 26, 2023
Associations between anemia and FGF23 in the CKiD study
Elizabeth Thomas, Alexandra M Klomhaus, Marciana L Laster, et al.
American Journal of Physiology. Renal Physiology
|
October 14, 2016
Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice
Mark R Hanudel, Kristine Chua, Maxime Rappaport, et al.
The Analyst
|
January 22, 2020
Measurement of serum phosphate levels using a mobile sensor
Aniruddha Ray, Sarah Esparza, Dimei Wu, et al.
JCI Insight
|
August 7, 2025
Transgenic augmentation of erythroferrone in mice ameliorates anemia in adenine-induced chronic kidney disease
Brian Czaya, Joseph D Olivera, Moya Zhang, et al.
JBMR Plus
|
April 18, 2022
Effects of Primary Kidney Disease Etiology on Renal Osteodystrophy in Pediatric Dialysis Patients
Ornatcha Sirimongkolchaiyakul, Katherine Wesseling-Perry, Barbara Gales, et al.
Plos One
|
September 6, 2019
Plasma total fibroblast growth factor 23 levels are associated with acute kidney injury and mortality in children with acute respiratory distress syndrome
Mark R Hanudel, Matthew S Zinter, Lucia Chen, et al.
Blood. Red Cells & Iron
|
February 2, 2026
Disease-modifying effects of iron deficiency in mouse models of chronic renal failure
Moya Zhang, Amber Lundin, Grace Jung, et al.
Kidney International
|
November 28, 2021
Enteral ferric citrate absorption is dependent on the iron transport protein ferroportin
Mark R Hanudel, Brian Czaya, Shirley Wong, et al.
Cancer Research Communications
|
September 13, 2024
Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis
Jack Pengfei Tang, Penelope Lafeuille, Alexandru Socolov, et al.
Page
of 5